Update affirms breast cancer treatment guidelines

The Clinical Practice Guide­lines in Oncology for Breast Cancer, published by NCCN, have been updated to affirm the existing recommendation regarding the use of bevacizumab (Avastin) for the treatment of metastatic breast cancer.